<DOC>
	<DOCNO>NCT00523458</DOCNO>
	<brief_summary>Because drug use treat TB reduce amount anti-HIV drug reach site virus locate , study design see whether necessary use high dos antiviral ( anti-HIV ) drug patient receive therapy rifampin , one drug commonly use treat TB . Participants assign one 4 arm ( see ) follow time receive treatment .</brief_summary>
	<brief_title>A Study Determine Best Dose Antivirals Patients With Both TB HIV</brief_title>
	<detailed_description>This open label , randomize study 4 arm : 1 . ) Standard dose 2 . ) high dose nevirapine ; 3 . ) standard dose 4 . ) high dose efavirenz . Subjects 4 arm also receive 2 nucleoside analog drug . Patients routine monitoring treatment TB HIV , well additional blood sample follow virus blood determine effect TB therapy amount anti-HIV drug body .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>ARV naïve subject Documented HIV infection Documented TB infection Platelet count 40,000/mm3 Hemoglobin ≥8.0 g/dL Absolute neutrophil count ( ANC ) &gt; 500/mm3 AST ( SGOT ) , ALT ( SGPT ) , alkaline phosphatase &lt; 3 X ULN Total bilirubin &lt; 2.5 x ULN Calculated creatinine clearance ≥60 mL/min For woman reproductive potential , negative urine pregnancy test Unable provide inform consent . History drug abuse investigator suspect interfere compliance study medication visit . Patients hemodialysis . Tuberculosis meningitis . Women CD4 &gt; 250 men CD4 &gt; 400 due high risk hepatotoxicity relate use NVP . Positive serology hepatitis C. Evidence active hepatitis B include positive serology HBsAg , HBeAg , HBVDNA . Note : If antiHBs positive , patient eligible study liver enzyme within parameter indicate inclusion criterion Women breastfeed Known allergy/sensitivity study drug ( ) formulation Patients OIs intercurrent illness could affect ability take study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Co-infection</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>HIV</keyword>
	<keyword>Drug interaction</keyword>
	<keyword>Non nucleoside reverse transcriptase inhibitor</keyword>
	<keyword>Therapy</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>